Policy papers and consultations

The government’s response to the Science, Innovation and Technology Committee’s report into the antimicrobial potential of bacteriophages.

• From: Department of Health and Social Care
• Updated: 1 March 2024

• Government's response to the Science, Innovation and Technology Committee's report 'The antimicrobial potential of bacteriophages'

  Presented to Parliament by the Secretary of State for Health and Social…

The full government response to the Lord O'Shaughnessy independent review of UK commercial clinical trials.

• From: Department of Health and Social Care
• Updated: 8 December 2023

• Full government response to the Lord O'Shaughnessy review into commercial clinical trials

  Ministerial foreword We welcome the areas highlighted by Lord…

Call for information to support a review of isotretinoin, a treatment for severe acne. This review is being undertaken by the Medicines and Healthcare products Regulatory Agency with advice from the Commission on Human Medic…

• From: Medicines and Healthcare products Regulatory Agency
• Updated: 28 April 2023

• Data Protection and Privacy Information

  1. Introduction You can read the MHRA Privacy Notice to find out in…

We are consulting on a set of proposals to improve and strengthen the UK clinical trials legislation to help us make the UK the best place to research and develop safe and innovative medicines

• From: Medicines and Healthcare products Regulatory Agency
• Updated: 21 March 2023

Public consultation on a set of proposals to make Gina 10 microgram vaginal tablets (Estradiol) available from pharmacies.

• From: Medicines and Healthcare products Regulatory Agency
• Updated: 20 July 2022